Seven synthetic analogues of the PXR (pregnane-X-receptor) potent natural agonist solomonsterol A were prepared by total synthesis. Their activity toward PXR was assessed by transactivation and RT-PCR assays. The study discloses cholestan disulfate (8) as a new, simplified agonist of PXR. By in vitro studies on hepatic cells we have demonstrated that this compound is a potent PXR agonist and functional characterization in human macrophages and hepatic stellate cells provided evidence that cholestan disulfate (8) has the ability to modulate the immune response triggered by bacterial endotoxin as well as to counter-activate hepatic stellate cell activation induced by thrombin. Because inhibition of immune-driven circuits might have relevance in the treatment of inflammation and liver fibrosis, the present data support the development of cholestan disulfate (8) in preclinical models of inflammatory diseases.
通过全合成制备了七种孕烃X受体(PXR)强效天然激动剂solomonsterol A的合成类似物。通过转录激活和RT-PCR检测评估了它们对PXR的活性。研究表明,胆甾烷二
硫酸盐(8)是一种新的、简化的PXR激动剂。通过对肝细胞的体外研究表明,该化合物是一种强效的PXR激动剂,并且在人巨噬细胞和肝星状细胞中的功能特性表明,胆甾烷二
硫酸盐(8)具有调节细菌内毒素引发的免疫反应的能力,同时能反向激活凝血酶诱导的肝星状细胞激活。由于抑制免疫驱动通路可能对治疗炎症和肝纤维化具有相关性,当前数据支持在炎症性疾病的临床前模型中开发胆甾烷二
硫酸盐(8)。